Introduction
============

Stroke is considered as one among the most common and major cerebrovascular pathological conditions ([@B1]). According to the recent survey, stroke is the second most cause of death (around 65 lakh deaths per year), and primary cause of severe and prolonged debility ([@B2]). Ischemic stroke accounts for more than 80% of the overall incidences of stroke, and it is a consequence of decreased blood supply to a small portion (focal) of the brain or complete brain (global) ([@B3]).

Many studies have reported that oxidative stress plays a crucial role in ischemia-reperfusion (I/R) brain injury ([@B4]). Though oxidative metabolism is highly essential for the survival of neurons, the exaggeration of the same leads to generation numerous oxidative free radicals ([@B5]). Under normal physiology, the reactive oxygen species are controlled by endogenous antioxidant defense mechanisms associated with the living system such as catalase, superoxide dismutase, glutathione system and so on, and thus maintains homeostasis ([@B6]). During I/R injury, the excess generation of reactive oxygen species leads to depletion or failure of endogenous antioxidant defense systems, and lead to accumulation of enormous free radicals ([@B7]). These toxic chemical entities initiate multifaceted cascades of various inflammatory events and apoptosis, that consequences in neuronal cell death. The injury to the neuronal tissue is displayed as functional (neurological, cognitive) and motor deficits, along with morphological (cerebral edema, infarction) and histopathological alterations of the brain tissue ([@B8]).

Based on the clear understanding of the disease, it is evident that the compounds belong to calcium channels blockers, excitatory neurotransmitter receptor blockers/antagonists, anti-inflammatory, antioxidants, and anti-apoptotic class may be beneficial in the treatment of cerebral stroke ([@B9], [@B10]).

In this context, various parts of *Punica granatum* L. (Punicaceae) have been extensively used in the traditional system of Indian medicine to treat varieties of illnesses ([@B11], [@B12]), and various parts of the plant have been scientifically proved for diverse biological activities such as antioxidant ([@B13]), anticonvulsant ([@B14], [@B15]), anti-Parkinson ([@B16]), anti- neuroinflammatory ([@B17]), anti-Alzheimer's ([@B18], [@B19]), memory enhancing ([@B20]), and protection against neonatal hypoxic-ischemic brain injury ([@B21], [@B22]). Considering the strong literature reports on antioxidant and neuroprotective actions of *P. granatum*, this study was designed to evaluate the effect of methanolic leaf extract of *P. granatum* on global I/R induced brain injury in Wistar rats.

Materials and Methods
=====================

***Drugs and Chemicals***

Quercetin, 2-thiobarbituric acid (TBA), 5-5-dithiobis (2-nitrobenzoic acid) (DTNB), trichloroacetic acid (TCA), and 2,3,5-triphenyltetrazolium chloride stain (TTC) were purchased from HiMedia Laboratories Pvt. Ltd. (Mumbai, Maharashtra, India). ELISA kits were procured from Krishgen (Krishgen Biosystems, Mumbai, India). LC-MS grade solvents were procured from Merck Ltd (Mumbai, Maharashtra, India).

***Plant material collection, handling, and extraction process***

The leaves of *P granatum* L. were harvested from Doddathekahalli, Sidlaghatta (T), Chikkaballapura (D), Karnataka, India during May-June. The plant material was recognized and authentified by Dr Madhavachetty, Associate professor, Botany Department, SV University, Tirupati, Andhra Pradesh, India. A sample of the plant part is conserved with voucher number 1213. The plant material was shade dried, powdered, and extracted at 60 ^°^C for 48 hr, with 70 % methanol using Soxhlet apparatus ([@B14]).

***In vitro antioxidant assays***

The MePG was evaluated using DPPH, FRAP and ORAC assays in *in vitro*.

*DPPH assay*

This assay was performed as per standard procedure mentioned in the literature. Shortly, 100 µl of 0.1 mM 2,2-diphenyl-1-picrylhydrazyl (DPPH) (in ethanol) was added to 100 µl of varied concentrations of the test drug solution prepared in water, and the mixture was incubated at room temperature for 30 min. Later, the absorbance was measured at 517 nm ([@B23]).

The DPPH radical scavenging capacity was calculated using the following equation:

DPPH Scavenged (%) =$\left( \frac{\mathit{Absorbance\ of\ control} - \mathit{Absorbance\ of\ test}}{\mathit{bsorbance\ of\ control}} \times 100 \right.$)

The assay was carried out in triplicate for each sample and the results were expressed as IC~50~ (µg/ml) values.

*FRAP assay*

This experiment was conducted as per well-established method given in the literature. The basic principle involves reduction of ferric ion to ferrous ion at low pH, which results in the formation of a colored complex called ferrous--tripyridyltriazin. The intensity of color formed is directly proportional to quantity of the product formed and it is estimated by recording the absorbance at 593 nm. The results are expressed as FRAP value ([@B24]).

*ORAC assay*

This experiment was carried out as per previously reported procedure by Rafiq *et al*. The Peroxyl radical formed from 2,2'-azobis (2-amidinopropane) dihydrochloride reacts with fluorescein (substrate) to give bright purple colored fluorescence. The capability of the test drug to decline the intensity of fluorescence is used as a measure of antioxidant activity. Results are expressed as Trolox equivalent/g of fresh sample, also called as ORAC value ([@B25]).

***In vitro RAW 264.7 cell line assay***

RAW 264.7 cells were procurement from the National Centre for Cell Science (NCCS), Pune, India and all the cell line experiments were carried out as per Viswanatha *et al.*, and Mathew *et al.* ([@B26], [@B27]).

***Experimental animals***

Inbred male Wistar rats (200--220 g, 8-10 weeks old) were preserved in polypropylene cages under standard housing conditions. The experimental animals were provided with standard rat diet and purified water *ad libitum*. All the experimental procedures were approved by the IAEC and the experiments were performed as per CPCSEA guidelines (CPCSEA, India).

***Study plan***

*Group classification*

Fifty male Wistar rats were allocated into five groups (n=10, G-1 to G-5), G-1 and G-2 named as Sham control, and I/R control respectively, these two groups received vehicle (0.5% CMC); the G-3 animals received quercetin (20 mg/kg, PO) which is a reference standard, whereas G-4 and G-5 groups received oral doses of MePG at 200 mg/kg, and 400 mg/kg, respectively. All the treatments were given for a span of seven days.

On day-8, all the experimental animals, excluding G-1 were exposed to 60 min of ischemia followed by 24 hrs reperfusion as per previously mentioned procedure ([@B26]). Subsequently, all the animals were evaluated for neurological, cognitive, and motor functions. Later, all the animals were sacrificed using isoflurane. The brain tissue was quickly collected, weighed, and the brain volume was assessed by displacement method, and subjected for the measurement of cerebral infarct size, biochemical estimations, and histopathology ([Figure 1](#F1){ref-type="fig"}).

*Formulation and administration of MePG*

The MePG was suspended in 0.5 % carboxy methyl cellulose for oral administration. The concentrations used for administration are 20 and 40 mg/ml. The sham control and I/R control animals received 0.5% CMC, at 10 ml/kg dose volume.

***Evaluation parameters***

*Neurological score*

There are four categories (0 to 3) of neurological findings were noted as follows: 0=no observed neurological deficits; 1=contralateral forelimb flexion with wrist flexion and shoulder adduction; 2=reduced resistance to lateral push; and 3=circling movements toward the ipsilateral side ([@B28]).

*Elevated plus maze test*

On Day-7 of the experiment, all the animals were trained on the elevated plus maze as per the previously published method ([@B29]). The transfer latency noted during training period is named as acquisition, whereas the transfer latency recorded after I/R insult is considered as index of retrieval and named as retention latency ([@B29]).

*Evaluation of motor functions*

*Hanging wire test (HWT) and pole fall test (PFT)*

These tests were performed as per previously explained procedure by Viswanatha *et al.* ([@B29]).

*Brain morphology*

Brain volume was estimated by displacement method, and used as an index of edema, while the TTC staining was performed as per published literature, which is used to determine cerebral infarction ([@B28]).

*Biochemical estimations*

Using the brain homogenate the biochemical parameters were determined as per standard methods published in the literature, namely the total protein content was estimated as per the Lowry's method ([@B30]); the catalase activity as per Luck ([@B31]), lipid peroxidation was determined as per Wills ([@B32]), reduced glutathione was estimated as per Sedlak and Lindsay ([@B33]). While, SOD activity was measured using commercially available superoxide dismutase estimation kit (Sigma-Aldrich, USA), as per manufacturer instructions ([@B34]).

*Assessment of inflammatory markers*

The TNF-α, IL-6, ICAM-I and IL-10 levels in the brain homogenate was assessed using commercially available ELISA kits (Krishgen Biosystems, Mumbai, India)**.**

*Histopathological evaluation*

In short, the brain tissue was fixed in 10% v/v neutral buffered formalin, and embedded in paraffin wax and made into 5 µm thick longitudinal section using microtome. Subsequently, the sections were stained with hematoxylin, and eosin for histopathological evaluation.

***Characterization of methanolic leaf extract of P. granatum***

*Total Phenolic content*

Total phenolic content in the extract was determined by Folin-Ciocalteu test ([@B35]).

*LC-MS/MS investigation of MePG*

The LC-MS/MS analysis was carried out using API 3000 Triple Quadrupole LC/MS/MS Mass Spectrometer (Perkin-Elmer Sciex Instruments, USA) and electron spray ionization source with an electron multiplier detector and a chromatographic system.

The amount of identified compounds present in the extracts were quantified using the equation given below ([@B28]).

$\mathit{Concentration\ in}\frac{\mathit{ng}}{\mathit{mg}} = \left( \frac{\mathit{sample\ area}}{\mathit{standard\ area}}\mathit{X}\frac{\mathit{standard\ dillution}}{\mathit{sample\ dillution}} \right) \times 1000$

***Statistical analysis***

The results of *in vivo* experiments were expressed as mean±SEM, and compared by One-way ANOVA followed by Tukey's multiple comparison test using Graph pad version 5.01 (Graph Pad Software, San Diego California USA). The *P\<*0.05 was considered to be statistically significant.

Results
=======

***In vitro antioxidant activity***

Initially, MePG was assessed in DPPH, FRAP, and ORAC assays for its antioxidant activity. In these assays, the MePG showed effective antioxidant property with a IC~50~ of 69.50±4.0 in DPPH assay, with a FRAP and ORAC value of 989.74±68.9 and 1229.8±117.3 respectively, in FRAP and ORAC assays. The results are depicted in [Table 1](#T1){ref-type="table"}.

***In vitro RAW 264.7 cell line assay***

In continuation with antioxidant assays, the MePG was assessed for its effect on generation of nitrite, ROS and TNF-α in LPS-activated RAW 264.7 cell lines. The cytotoxicity assessed by MTT assay revealed that the MePG exhibits very negligible cytotoxicity with IC~50~(µg/ml of 1826.7±157.7. Thus, for all remaining experiments doses were selected between 12.5 to 200 µg/ml.

Notably, the MePG has significantly inhibited the generation of nitrite and ROS with IC~50~ values of 179.32

µg/ml and 129.93 µg/ml respectively. Likewise, the standard compounds DPI and L-NAME have displayed significant inhibition with an IC~50~of 4.44 and 44.38 µg/ml respectively. Also, the MePG has shown significant inhibition of TNF-α generation with an IC~50~ of 206.16 µg/ml. These outcomes further witnessed the strong antioxidant property of MePG and also gave a clue about the strong anti-inflammatory property of MePG ([Figure 2A, 2B, 2C](#F2){ref-type="fig"}).

***Effect of MePG on I/R-induced brain injury***

In our earlier study, we have evaluated the anticonvulsant activity of MePG in experimental animals and we observed that the MePG exhibits potent anti-epileptic activity through GABA mediated mechanisms. In this study, the MePG showed significant antioxidant and anti-inflammatory activities. Considering these outcomes, we have further assessed the significance of MePG (200 and 400 mg/kg) treatment against I/R-induced brain injury in Wistar rats.

***Effect of MePG on I/R-induced neurological, motor, and cognitive deficits***

In present study, severe neurological deficits were observed in the I/R control animals (F ~4,\ 46~ =16.27, *P*\< 0.01) compared to sham control ([Figure 3](#F3){ref-type="fig"}). Moreover, in motor functional tests, a substantial decline in the falloff latencies were noted, in both PFT (F ~4,\ 46~ =9.18, *P*\<0.01) and HWT (F ~4,\ 43~ =7.99, *P*\<0.01) in I/R control group compared to sham control ([Figure 4A and 4B](#F4){ref-type="fig"}). Besides, the EPM test performed before I/R induction revealed that there was no significant difference in TL among the different groups (during training phase). In contrary, after subjecting to I/R insult, there was a significant increase in TL was noted in I/R control group compared to sham control (F ~4,\ 42~ =28.06, *P*\<0.01) ([Figure 5A, 5B and 5C](#F5){ref-type="fig"}). Remarkably, quercetin (20 mg/kg, PO) and MePG (200 and 400 mg/kg, PO) pretreatment for 7 days, have offered substantial protection against I/R-induced neurological (F ~4,\ 46~ =16.27, *P*\<0.001; *P*\<0.01; *P*\<0.001, respectively), motor (F ~4,\ 46~ =9.18; F ~4,\ 43~ =7.99, *P*\<0.001; *P*\<0.01; *P*\<0.001, respectively), and cognitive deficits (F ~4,\ 42~ =28.06, *P*\<0.001; *P*\<0.05; *P*\<0.001, respectively) compared to I/R control group ([Figure 3](#F3){ref-type="fig"}; [Figure 4A and 4B](#F4){ref-type="fig"}; [Figure 5A, 5B and 5C](#F5){ref-type="fig"}).

***Effect of MePG on I/R-induced cerebral edema and infarction***

Followed by I/R insult, the I/R control group has exhibited obvious pathological changes, as observed in TTC staining ([Figure 6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}). Additionally, the I/R control animals (F ~3,\ 32~ =16.96, *P* \<0.01) showed increase in brain volume by 20.34±1.31 % compared to sham control group ([Figure 6](#F6){ref-type="fig"}). Further, the TTC staining revealed that there was approximately 20.96±0.87 % (F ~4,\ 25~ =131.1, *P*\<0.01) of the infarct area in the I/R control group ([Figure 6](#F6){ref-type="fig"}). These observations (cerebral edema and infarction) were consistent with the previously published reports.

However, the sham control animals displayed 1.22±0.1% infarct area, out of total area of the brain. Interestingly, seven days pretreatment with quercetin (20 mg/kg; *P*\<0.01) and MePG (200 and 400 mg/kg ; *P*\<0.01 and *P*\<0.001, respectively) have offered significant protection against I/R-induced cerebral edema and infarction in Wistar rats ([Figure 6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}).

***Estimation of biochemical parameters***

The cerebral ischemia and reperfusion is well-known to triggers the formation of enormous amount of free radicals and results in the brain injury. In the present study, the ischemia and reperfusion has deteriorated the defensive antioxidant systems and increased the generation of toxic free radicals, it was clearly evident in I/R control group compared to sham control. Predominantly, the enzyme activities of catalase (F ~4,\ 35~ =27.08, *P*\<0.01), and SOD (F ~4,\ 35~ =16.90, *P*\<0.01) were significantly diminished, associated with substantial decline in the GSH levels (F ~4,\ 35~ =8.45, *P*\<0.01), along with increase in MDA (F ~4,\ 35~ =15.07, *P*\<0.01) levels in the I/R control group compared to sham control. Remarkably, pretreatment with quercetin (20 mg/kg, PO), and MePG (200 and 400 mg/kg, PO) for seven days, have shown significant protection against I/R-induced altered enzymatic (increased catalase and SOD activities) and non-enzymatic antioxidant systems (increased GSH, reduced MDA), the results are given in [Figure 8A, 8B](#F8){ref-type="fig"}, [9A, and 9B](#F9){ref-type="fig"}.

Additionally, the pro-inflammatory markers namely, TNF-α (F ~4,\ 25~ =26.15, *P*\<0.01), IL-6 (F ~4,\ 25~ =16.93, *P*\<0.01) and ICAM-I (F ~4,\ 25~ =11.24, *P*\<0.01) were significantly increased, along with profound decrease in the levels of IL-10 (F ~4,\ 25~= 7.61, *P*\<0.01) in the I/R control group compared to sham control. Interestingly, the quercetin and MePG pretreatments have enhanced the levels of anti-inflammatory cytokine (IL-10) and decreased the levels of pro-inflammatory cytokines (TNF-α, IL-6, and ICAM-I) compared to I/R control. The results are given in [Figure 10A, 10B, 10C, and 10D](#F10){ref-type="fig"}.

***Histopathology of brain***

In the present study, histopathology of sham control group showed normal anatomical structure of the brain tissue. However, the I/R-control animals have exhibited clinical signs of I/R-induced brain injury, such as vascular congestion, cerebral edema, and leukocyte infiltration, accompanying with the necrosis of the brain tissue. Interestingly, MePG (400 mg/kg, PO) and quercetin (20 mg/kg, PO) treatments have ameliorated the I/R induced histopathological changes significantly, and showed very mild cerebral edema and vascular congestion. However, MePG (200 mg/kg, P.O.) treated group displayed minimal vascular congestion, inflammatory changes and cerebral edema as a sign of mild protection against I/R injury. Prominently, the MePG (400 mg/kg, PO) and quercetin (20 mg/kg, PO) have completely abolished the I/R-induced necrosis of brain tissue. These findings suggest that, the MePG and quercetin have substantially alleviated I/R-induced histological changes in the brain tissue. The histopathological images are depicted in [Figure 11](#F11){ref-type="fig"}, and the severity scoring is given in Supplementary data file 1.

***Chemical characterization of MePG***

*Total phenolic content (TPC)*

The MePG exhibited a TPC of 95.67 mg gallic acid equivalents per gram of the extract (9.56%).

*LC-MS/MS analysis of MePG*

The LC-MS/MS analysis of MePG showed the occurrence of acteoside, apigenin, gallic acid, gossypin, pentagalloyl glucose, quercetin, and rutin. Additionally, LC-MS/MS quantification showed that, the MePG comprised of 11653.09 ng/mg of pentagalloyl glucose, 685.26 ng/mg of gallic acid, 462.41 ng/mg of apigenin, 294.23 ng/mg of rutin, 38.03 ng/mg of quercetin, 21.13 ng/mg of gossypin, 7.96 ng/mg of acteoside as major phytoconstituents. The results of LC-MS/MS investigations are given in Supplementary data file 2 and 3.

Discussion
==========

In our earlier study, we have assessed the anti-epileptic activity of *P. granatum*leaf extracts and we have observed that the MePG exhibits noteworthy anti-epileptic property in animal models of epilepsy ([@B14]).

Ischemia-reperfusion and other forms of oxidative stress generate extremely reactive and toxic free radicals by numerous biochemical reactions such as electron transport chain (ETC). These free radicals, particularly oxidative and nitrosative radicals further activate the expansion of these toxic chemicals, through reactions like fenton reaction. The RNS and ROS formed will interact with vital biomolecules such as cellular proteins, lipids, and nucleic acids, and cause denaturation. The denaturation consequences in the abnormal functioning of the cell/tissues located at the site of injury. In these lines, many studies have proved that the secondary metabolites of plant origin such as flavonoids, glycosides, saponins and polyphenolic compounds, are capable of scavenging and/or neutralizing the deleterious effects of these toxic free radicals. Hence it is perceived that, these molecules could counter the significances of stroke, either by preventing the formation of free radicals and/or scavenging the generated radicals ([@B6]).

In this study, the total phenolic content analysis revealed that the MePG contains 95.67 mg GE/g of phenolic content. Further, LC-MS/MS analysis of MePG showed the presence of pentagalloyl glucose, gallic acid, apigenin, and rutin as major phytoconstituents, thus the MePG is established to contain a high amount of bioactive compounds such as polyphenols. It is widely reported that phenolic compounds such as phenolic acids, tannins, flavonoids, and phenyl propanoids are well-established to possess potent free radical scavenging and antioxidant activities. There exists a linear relationship between the total phenolic content and antioxidant activity, also these molecules are well established to play a crucial role in the prevention of NO and peroxynitrite production ([@B35]-[@B37]). In line with the above statement, the MePG showed highly significant free radical scavenging and antioxidant activities in the *in vitro*antioxidant assays.

Based on the chemical profiling and *in vitro* antioxidant assay outcomes, the MePG was further assessed for its consequence on generation of nitrite, ROS and TNF-α in LPS-activated RAW 264.7 cell lines *in vitro*.

The murine macrophage cell line RAW 264.7, is a widely used test for assessing the antioxidant and anti-inflammatory activity of the test compounds. The incubation of RAW 264.7 cells with lipopolysaccharides, activate the complex cascade of inflammatory events that produces inflammatory cytokines such as TNF-α, IL-6, IL-1β, IL-8, and augments the expression of nuclear factors such as NF- κB and AP-1. Also generates enormous amount of ROS, and nitrite along with the activating the nuclear enzyme called poly ADP-ribose polymerase (PARP). Importantly, in this assay both anti-inflammatory and antioxidant activity of the test compounds can be assessed concurrently. The ROS, and nitrite estimations could help as markers of antioxidant activity and pro-inflammatory cytokine (TNF-α, IL-6, IL-1β, IL-8) estimation served as a marker of anti-inflammatory activity.

In the present study, the MePG has significantly alleviated the generation of nitrite, ROS and TNF-α in RAW 264.7 cell line assay and thus showed potent anti-inflammatory and antioxidant activities. Further, the MePG produced very low level of cytotoxicity in MTT assay, with an IC~50~ of 1826.7 ± 157.7 µg/ml.

Based on the notable outcomes of *in vitro* antioxidant and RAW 264.7 cell line assays, the MePG was further evaluated against global ischemia and reperfusion-induced brain injury in Wistar rats.

BCCO followed by reperfusion in rats, is a well-known and most widely used model for screening the cerebroprotective effect of test drugs ([@B38]). In literature, the role of ROS in the pathogenesis of I/R-induced brain injury has been well documented ([@B7], [@B9], [@B29]). It is understood that, during cerebral ischemia the ROS are generated mainly through activation of phospholipase A~2~ and inhibition of electron transport chain ([@B29]). Moreover, the reperfusion phase after the acute cerebral ischemia, will aggravate the generation of toxic free radicals ([@B7]). Evidently, the neuronal tissue is highly enriched with polyunsaturated fatty acids and known to have a very weak endogenous antioxidant defense system, and hence the brain tissue is regarded as highly sensitive to oxidative/free radical damage ([@B38]). Therefore, the free radical produced throughout the I/R would denaturate the biomolecules of the neurons through complex cascades of events, which lead to neuroinflammation, and apoptotic neuronal cell death. The damage caused to the neuronal tissue will be demonstrated as neurological, cognitive, motor, and behavioral functional deficits along with the morphological and histological changes of the brain tissue ([@B29]).

In this study, we have evaluated the neurological, cognitive, and motor functions to explore the effect of MePG on I/R-induced functional deficits. Additionally, the cerebral edema, infarct formation, and histopathological evaluations were performed.

In the observations, I/R control animals exhibited noticeable neurological, cognitive, and motor functional deficits compared to sham control. Nevertheless, pretreatment with MePG and quercetin have offered significant protection against I/R-induced neurological, cognitive, and motor functional deficits.

Moreover, the I/R and other forms of brain injuries are often linked with the cerebral edema. The increase in brain volume intend increase the intracranial pressure, the increased intracranial pressure results in the neuronal injury due to compression, and the end consequences of all these events is diminished blood supply to the site of injury ([@B39]). Consistent with the previously published reports, in this study the I/R control animals showed a substantial increase in brain volume compared to sham control. Especially, the MePG and quercetin treatments have offered noteworthy protection against I/R-induced cerebral edema.

In the present study, the morphology of I/R control animals exhibited significantly high levels of cerebral infarction compared with sham control, which is a cardinal sign of severe brain damage; nevertheless, MePG and quercetin pretreatments have ameliorated the I/R-induced cerebral infarction compared to I/R control group.

Further, during the I/R-injury enormous amount of free radicals are generated due to oxidative stress, initially superoxide radical is formed, and further, a cascade of various biochemical reactions trigger the generation of ROS and RNS. The endogenous antioxidant defense mechanism comprises of SOD, catalase and glutathione systems, are noticed to be highly distressed during the I/R-induced brain injury, which is accompanied by increased lipid peroxidation (quantified by estimating the levels of MDA) in the brain homogenate ([@B29]).

![Illustration of detailed experimental protocol](IJBMS-22-187-g001){#F1}

![Effect of MePG on LPS-stimulated RAW 264.7 cell lines*in vitro*Note: MePG--methanolic leaf extract of *Punica granatum*, L-NAME: NG-Nitro-L- arginine methyl ester, TNF-α: tumor necrosis factor alpha. A--LPS -induced ROS generation, B--LPS -induced nitrite elevation, C--LPS- induced TNF-α elevation. Figure Legend: All the values (IC~50~ values) are expressed as mean±SEM (N=3). The MePG (12.5 to 200 µg/ml) was evaluated against LPS-stimulated ROS, nitrite and TNF-α generation *in vitro*. The MePG has significantly inhibited the LPS-stimulated ROS, nitrite and TNF-α generation in RAW 264.7 cell lines](IJBMS-22-187-g002){#F2}
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![Effects of MePG on I/R-induced motor deficits in Wistar rats](IJBMS-22-187-g004){#F4}
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![Effect of MePG on I/R induced altered GSH and lipid peroxidation in Wistar rats](IJBMS-22-187-g009){#F9}

![Effect of MePG on I/R-induced altered TNF-α, IL-6, IL-10 and ICAM-I levels](IJBMS-22-187-g010){#F10}

![Effect of MePG on I/R-induced histological changes of brain tissue Note: The pictures represent the histopathology of the brain tissue of various treatment groups along with control and I/R control groups.](IJBMS-22-187-g011){#F11}

###### 

Evaluation of *in vitro* antioxidant activity of methanolic leaf extract of *P. granatum*

  **Sample**      **Antioxidant activity** [\*](#TFN1){ref-type="table-fn"}                     
  --------------- ----------------------------------------------------------- ----------------- ----------------
  **MePG**        69.50 ± 4.0                                                 989.74 ± 68.9     1229.8 ± 117.3
  **Vitamin C**   25.30 ± 1.8                                                 1416.81 ± 121.3   3418.4 ± 221.2

**Note:** DDPH, 2, 2, Diphenyl-1-picrylhydrazyl; FRAP, Ferric reducing antioxidant power; ORAC, oxygen radical absorbance capacity; TE, Trolox equivalents; MePG, Methanolic leaf extract of *P. granatum*.

The values are expressed as mean ± SD for three trials carried out for each assay.

To investigate the above mentioned hypothesis, we have assessed SOD and catalase enzyme activities along with the quantification of MDA and GSH levels in the brain homogenate. In the observations, the I/R control animals exhibited a decline in SOD and catalase enzyme activities, along with the reduction in GSH, and increase in the MDA levels compared to sham control. In contrary, pretreatment with quercetin and MePG showed significant protection against I/R-induced altered antioxidant enzyme (SOD and catalase) activities, and sustained the levels of MDA and GSH near to sham control. These outcomes are in mutual agreement with the antioxidant activity of MePG observed in the *in vitro* assays.

In the literature it is well reported that, throughout I/R-injury the activated microglia generate an enormous amount of pro-inflammatory cytokines such as TNF-α, IL-6, IL-1β, and ICAM-I; associated with substantial decline in the levels of anti-inflammatory cytokines like IL-10 ([@B40]).

To explore the possible anti-neuroinflammatory property of MePG, we have assessed TNF-α, IL-6, ICAM-I and IL-10 levels in the brain homogenate by ELISA. Consistent with literature reports, significant elevation of TNF-α, IL-6, and ICAM-I with a substantial decline in IL-10 levels was observed in the I/R control. However, pretreatment with quercetin and MePG have attenuated the I/R- induced elevation of pro-inflammatory cytokines (TNF-α, IL-6, ICAM-I), and increased the levels of anti-inflammatory cytokine (IL-10) compared to I/R control group.

Moreover, histopathological evaluation of brain tissue further confirmed the outcomes recorded in the functional, morphological and biochemical estimations. Interestingly, sham control animals showed normal histology of brain without any abnormalities, while the I/R control group exhibited indications of brain injury such as congestion of blood vessels, cerebral edema, leukocyte infiltration, and necrosis of brain tissue. Nevertheless, quercetin and MePG pretreatments have alleviated the I/R-induced histological changes and displayed substantial protection against I/R-induced brain injury.

Further, mentioning on the phytoconstituents accountable for the cerebroprotective effect, the MePG was found to be rich in phenolic compounds, and LC-MS/MS analysis of MePG showed the existence of acteoside, apigenin, gallic acid, gossypin, pentagalloyl glucose, quercetin, and rutin as major phytoconstituents.

Remarkably, several studies have shown that the phytoconstituents of MePG, such as apigenin ([@B41]), gallic acid ([@B42]), gossypin ([@B43]), pentagalloyl glucose ([@B29]), quercetin ([@B44]), and rutin ([@B45], [@B46]) are scientifically well established for their protective effects against I/R-induced brain injury. Hence, the cerebroprotective activity of MePG witnessed in the present study is believed to be due to the synergistic effect of these compounds.

Conclusion
==========

Based on these findings, we conclude that methanolic leaf extract of *P. granatum*exhibits substantial cerebroprotective action against I/R-induced brain injury in Wistar rats.
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